Policy and Politics: What Cancer Advocates Must Understand
Clinical Trial: MGUS and Smoldering Myeloma Observational Study on Genomic Predictors of Progression
Myeloma 101: Vaccinations After Myeloma Stem Cell Transplant
An Algorithm to Predict GvHD Post Allogeneic Stem Cell Transplants
High-Risk Multiple Myeloma Patients Benefit from Aggressive Treatment
Sugar's Smoke Screen and Cancer Cell Immunity
Studying MGUS and Smoldering Myeloma Genetics and Using Immunotherapies in High-Risk Smoldering Myeloma with Dr. Elisabet Manasanch, MD Anderson Cancer Center
Dr. Elisbet Manasanch at MD Anderson Cancer Center is using myeloma genetics testing to help determine answers to this important question.
Muscles for Myeloma: Exercise After Stem Cell Transplant
Improving the Cancer Patient Experience by Listening to Patients at MD Anderson
Full Show: Myeloma Therapy Using Intraveneous Vitamin C with Dr. Guido Tricot, MD, PhD, University of Iowa
All you ever wanted to know about Immunomodulators (IMiDs) for Multiple Myeloma
A New Bone Strengthener for Myeloma Patients
Muscles for Myeloma: Interleukin-6, Myeloma and Exercise
Clinical Trial: UPENN's BCMA CAR T Cell Clinical Trial for Myeloma Relapsed/Refractory Patients
Riding the Myeloma Roller Coaster Part 2: Patient Tips on How to Cope
Uncovering MGUS Mysteries: Should We Be Screening More for MGUS?
Myeloma Therapy Using Intraveneous Vitamin C with Dr. Guido Tricot, MD, PhD, University of Iowa
Dr. Tricot shares how they tested it with carfilzomib, bortezomib and the chemotherapy melphalan.
Don’t Obsess About Cancer Causes
The Myeloma Genome Project with Dr. Gareth Morgan, UAMS Myeloma Institute
Many are working to collect genomic data from myeloma patients with the goal of segmenting patients into groups that could lead to more personalized therapy
Mayo Clinic Recommendations for Myeloma Therapy at First Relapse
Muscles for Myeloma: Myeloma is not a Sprint, it's a Marathon
University of Iowa Myeloma Researchers Find Vitamin C Mega Doses Kills Myeloma Cells
Beneficial Cytoxan
Living Long-Term With Myeloma Part 1: Infections, Immunity and Vaccines
